Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Durvalumab with Gemcitabine and Cisplatin for Patients with Muscle-Invasive Bladder Cancer
FranceStudy on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer
FranceStudy on Luspatercept for Treating Anemia in Adults with Myelofibrosis on JAK2 Inhibitor Therapy Requiring Red Blood Cell Transfusions
FranceStudy on Ravulizumab for Patients with Thrombotic Microangiopathy After Stem Cell Transplant
FranceStudy on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)
FranceStudy of tucatinib, pertuzumab and trastuzumab combination for patients with HER2-positive metastatic breast cancer who have brain metastases after local therapy
FranceStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
FranceComparing drug combinations with panitumumab for patients with RAS and B-RAF wild-type metastatic colorectal cancer
FranceStudy comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer
FranceStudy on Chemotherapy with Paclitaxel, Cisplatin, and Carboplatin for Patients with Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer
FranceStudy of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery
FranceStudy on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
